Sign In |Help & Support
HOMECHINA STANDARDSICS CLASSIFICATIONINDUSTRY CLASSIFICATIONCHINESE CLASSIFICATIONCART(0)
ALL SECTORS
  • ALL SECTORS
  • GB(National Standard)
  • CB(Shipping)
  • CECS(Engineering Construction)
  • CJ(Urban Construction)
  • CY(News and Publication)
  • DB(Provincial Standard)
  • DL(Electricity & Power)
  • DZ(Geology & Mineralogy)
  • FZ(Spinning & Textile)
  • GA(Public Security)
  • HB(Aviation)
  • HG(Chemical Industry)
  • HJ(Environmental Protection)
  • JB(Machinery)
  • JC(Building Materials)
  • JG(Building & Construction)
  • JJ(Metering)
  • JT(Highway & Transportation)
  • LY(Forestry)
  • MT(Coal)
  • NB(Energy)
  • NY(Agriculture)
  • QB(Light Industry)
  • QC(Automobile & Vehicle)
  • QJ(Aerospace)
  • SH(Petrochemical)
  • SJ(Electronics)
  • SL(Water Resources)
  • SN(Commodity Inspection)
  • SY(Oil & Gas)
  • TB(Railway & Train)
  • YB(Ferrous Metallurgy)
  • YC(Tobacco)
  • YD(Telecommunication)
  • YY(Medical Device)
Database: 365,228(8 Aug 2026)
  1. HOME
  2. Standards for Stage I tumor

Stage I tumor

Stage I tumor, Total:71 items.

The international standard classification for "Stage I tumor" includes: Occupational safety. Industrial hygiene , Medical Sciences and health care facilities in general , Quality , Radiographic equipment .

The Chinese standard classification for "Stage I tumor" includes: Diagnostic standard for occupational diseases , Sanitation in general , Medical apparatus and devices in general .

Professional Standard - Agriculture

Occupational Health Standard of the People's Republic of China

Anhui Provincial Standard of the People's Republic of China

General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China

  • GBZ 94-2017 Diagnosis of Occupational Tumors
  • GB 16386-1996 Diagnostic criteria and principles of management of radiogenic neoplasms
  • GBZ 97-2017 Judgment standard for occupational radiogenic neoplasms

Group Standards of the People's Republic of China

  • T/CHIA 18-2021 Standard for dataset of cancer registration in China
  • T/WEBIO 0003-2024 Technical Specifications for Freezing and Thawing of Human Tumor Tissue Activity
  • T/JSSG 011-2022 Service specifications on medical social work of tumor hospital
  • T/GDC 273-2024 Specification for tumor imaging information data elements
  • T/CACM 1291-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Malignant Lymphoma
  • T/CRHA 055-2024 Specification on the clinical application of 3D visualization in liver tumors
  • T/CAMDI 122-2023 General requirements for 3D-bioprinted tumor model
  • T/GDNAS 014-2022 Standardized nursing assessment of patients prior to cancer chemotherapy
  • T/CACM 1243-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Multiple Myeloma
  • T/CACM 1172-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Cervical Cancer
  • T/CAWAORG 010-2023 Evaluation criteria for county cancer prevention and treatment centers
  • T/CRHA 145-2025 Technical Specifications for Collection of Human Tumor Biological Sample Information
  • T/CHSA 004-2023 Expert consensus on management of parotid gland malignancy
  • T/CITS 235-2025 Technical Specifications for Circulating Tumor Cell Detection
  • T/SHDSGY 040-2023 Standard for the construction of intelligent nursing platform for tumor rehabilitation
  • T/GDNAS 006-2022 Prevention and nursing care of PICC-related thrombosis in cancer patients
  • T/SHNA 0008-2024 Complete decongestive therapy for patients with lower extremity lymphedema after treatment of gynecological cancer
  • T/CITS 324-2025 Quality Assurance Requirements for Circulating Tumor Cell Detection Technology
  • T/CACM 1261-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Bladder carcinoma
  • T/CHSA 004-2020 Guidelines for pathological diagnosis of salivary gland tumors
  • T/CACM 1217-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Pancreatic cancer
  • T/CRHA 134-2025 Management Specifications for Intravenous Infusion of Antineoplastic Drugs
  • T/SHDSGY 167-2023 Technical specification for the construction of brain tumor organoid models
  • T/GDPHA 028-2021 Standard Data Set of Clinical Research on Malignant Tumor Diseases
  • T/GDNAS 011-2022 Prevention and nursing of hand-foot syndrome associated with tumor chemotherapy

Professional Standard - Hygiene

  • WS/T 559-2017 Dietary guidance for patients with malignant tumors
  • WS/T 555-2017 Subjective overall nutritional assessment in cancer patients

Beijing Provincial Standard of the People's Republic of China

Shanxi Provincial Standard of the People's Republic of China

  • DB14/T 2992-2024 Standards for multidisciplinary diagnosis and treatment of medical oncology

Jiangsu Provincial Standard of the People's Republic of China

National Health Commission of the People's Republic of China

  • GBZ 97-2002 Diagnostic criteria for radiogenic neoplasms

Jilin Provincial Standard of the People's Republic of China

  • DB22/T 1862-2013 Hygienic protection norms for the application of antineoplastic drugs
  • DB22/T 2367-2015 Regulations for the management of clinical application of antineoplastic drugs

Guangdong Provincial Standard of the People's Republic of China

Shanghai Provincial Standard of the People's Republic of China

  • DB31/T 1116-2018 Specifications for 18F-FDG PET/CT tumor imaging reporting elements

Chongqing Provincial Standard of the People's Republic of China

  • DB50/T 933-2019 Technical Regulations on Cultivation Measures to Control Stem Mustard Clubroot

Jiangxi Provincial Standard of the People's Republic of China

  • DB36/T 1788-2023 Tumor registration reporting and management practices for medical institutions

Ente Nazionale Italiano di Unificazione

  • UNI/PdR 130:2022 Aesthetics services for oncological patients - Oncological Aesthetics Specialist

Clinical and Laboratory Standards Institute

  • CLSI MM23-2015 Application of molecular diagnostic methods in solid tumors (non-hematological malignancies)

Gosstandart of Russia

  • GOST R 57005-2016 Diagnostics in oncology. Screening. Cervical cancer
  • GOST R 57003-2016 Diagnostics in oncology. Diagnostic algorithms. Solid intrathoracic tumors. Laboratory stage
  • GOST R 57004-2016 Diagnostics in oncology. Diagnostic algorithm. Cervix. Laboratory stage

American Petroleum Institute (API)

  • API 30-31999-1982 THE OCCURRENCE AND NATURAL HISTORY OF EXPERIMENTAL SKIN TUMORS
  • API PUBL 36-32643-1989 Short-Term Dermal Tumorigenesis Study of Selected Petroleum Hydrocarbons in Male CD-1 Mice Initiation and Promotion Phases

the tumor,tumor immunity,tumor immunity,tumor data,Tumor week,tumor front,Stage I tumor,Tumor week,immune tumor,tumor tumor,Stage I tumor,tumor antigen,deuterium tumor,Tumor week,flow + tumor,tumor reagent,tumor reagent,Immuno-oncology tumor,Antitumor Drugs|Tumor|Tumor Pharmacodynamics|Tumor Diagnosis and Treatment|Tumor Cells|New Antitumor Drugs

All Rights Reserved © 2026 WWW.CHINASTANDARDS.NET visa master american express unionpay apple pay paypal google pay